BioCentury
ARTICLE | Financial News

ApoGen completes venture financing

December 14, 2016 11:05 PM UTC

ApoGen raised $7 million in a series A round from Accelerator Corp., AbbVie Ventures, Alexandria Venture Investments, Arch Venture Partners, Eli Lilly and Co., Johnson & Johnson Innovation-JJDC, Watso...

BCIQ Company Profiles

ApoGen Biotechnologies Inc.